Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nanovibronix Inc (NAOV)

Nanovibronix Inc (NAOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nanovibronix Inc 969 PRUITT AVE TYLER TX 77569 USA

www.nanovibronix.com Employees: 31 P: 914-233-3004

Sector:

Medical

INDUSTRY GROUPING:

Medical Instruments

Description:

NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.

Key Statistics

Overview:

Market Capitalization, $K 4,375
Enterprise Value, $K 3,625
Shares Outstanding, K 1,088
Annual Sales, $ 2,560 K
Annual Net Income, $ -3,710 K
Last Quarter Sales, $ 720 K
Last Quarter Net Income, $ 510 K
EBIT, $ -9,450 K
EBITDA, $ -9,450 K
60-Month Beta 2.05
% of Insider Shareholders 5.20%
% of Institutional Shareholders 16.39%
Float, K 1,032
% Float 94.80%
Short Interest 23
Short Float 0.00%
Short Volume Ratio 0.21

Growth:

1-Year Return -93.91%
3-Year Return -99.45%
5-Year Return -99.78%
5-Year Revenue Growth 383.02%
5-Year Earnings Growth 92.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.91 on 11/14/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -41.74
EPS Growth vs. Prev Qtr 11.65%
EPS Growth vs. Prev Year 97.70%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 08/12/25

NAOV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.78%
Return-on-Assets % -19.24%
Profit Margin % -144.92%
Debt/Equity 0.02
Price/Sales 1.83
Price/Cash Flow N/A
Price/Book 0.10
Book Value/Share 42.04
Interest Coverage -35.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar